Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.

Wright, T J, McKee, C, Birch-Machin, M A, Ellis, R, Armstrong, Jane and Lovat, P E (2013) Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. Clinical and Experimental Dermatology. ISSN 1365-2230

Full text not available from this repository.
Item Type: Article
Subjects: Sciences > Pharmacy and Pharmacology
Divisions: Faculty of Applied Sciences
Faculty of Applied Sciences > Department of Pharmacy Health and Wellbeing
Health Sciences and Wellbeing Beacon
Health Sciences and Wellbeing Beacon > Drug Discovery and Application Workstream
Depositing User: Glenda Young
Date Deposited: 18 Apr 2013 11:08
Last Modified: 18 Apr 2013 11:08
URI: http://sure.sunderland.ac.uk/id/eprint/3804

Actions (login required)

View Item View Item